Omega-3 vs TB-500 for pain & inflammation
Short answer: For pain & inflammation, more users report improvement with Omega-3 — 93% of 112 reports, versus 86% of 199 for TB-500.
Omega-3 has 1,341 meta-analyses and 3,093 randomized trials on PubMed; TB-500 has 0 and 3.
Based on 3,026 reports about Omega-3 and 874 about TB-500. Not medical advice.
| Omega-3 Supplement | TB-500 Peptide | |
|---|---|---|
| Users say it helped | 69%helped968 reports · high confidence | 65%helped402 reports · high confidence |
| Verdict | Mostly positive | Mostly positive |
| Research | AResearch: Strong | CResearch: Limited |
| Meta-analyses / RCTs | 1,341 / 3,093 | 0 / 3 |
| Mainly used for | ||
| Recovery % reporting improvement | 90% (31) | 96% (297) |
| Pain & inflammation % reporting improvement | 93% (112) | 86% (199) |
| Mood % reporting improvement | 86% (289) | 91% (11) |
| Focus % reporting improvement | 85% (172) | 50% (2) |
| Heart & lipids % reporting improvement | 83% (108) | 60% (5) |
| Common side effects | fish burps, stomach issues, vivid dreams, fishy burps | anxiety, fatigue, dizziness, allergic reaction |
| Typical dose reported | 500/250 mg / daily | Not listed |
Omega-3Full Omega-3 profile →
Latest review conclusion
For glycated hemoglobin, there was no significant effect in the meta-analysis. This systematic review with meta-analysis demonstrated that supplementation with omega-3 has protective effects on diabetes parameters.
Crit Rev Food Sci Nutr, 2022 ↗What a user said
“I do supplement a lot of fish oil and vitamin A as retinyl palmitate though. It has really helped my depression, anxiety and ADHD and has enabled me to stop using more serious psychiatric drugs for those things.”
TB-500Full TB-500 profile →
What a user said
“They reduce neuroinflammation in the brain caused by either head injuries or drug abuse. Ive used them both for this and it works.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate